In contrast, NSG data from one congenital sideroblastic anaemia patient carrying an ALAS2 mutation and other healthy donors showed a multi-lineage engraftment with high a percentage of the lymphoid/myeloid cell ratio. Here, ALAS2 is linked to sideroblastic anemia.